IP Library Granted Patent US 11,467,091
Granted Patent B2
US 11,467,091 · App. 16/325,632 · Granted Oct 11, 2022

Bodily emission analysis

Inventors: Ishay Attar (M.P. Hof Carmel, IL); Yaara Kapp-Barnea (Nirit, IL)
Assignee: OUTSENSE DIAGNOSTICS LTD.
G01N21/6486A61B10/007A61B10/0038G01J3/10G01J3/2803G01J5/0806G01J5/0808G01J5/10G01N21/31G01N21/645G01N33/493A61B2010/0006E03D11/13G01J3/42G01J2003/104G01N33/57419G01N2021/6421
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,467,091
App. No.
16/325,632
Granted
Oct 11, 2022
Kind
B2
Abstract

Apparatus and methods are described for use with feces of a subject that is disposed within a toilet bowl ( 23 ), and an output device ( 32 ). One or more light sensors ( 60, 62, 64, 66 ) receive light from the toilet bowl, while the feces are disposed within the toilet bowl. A computer processor ( 44 ) analyzes the received light, and, in response thereto, determines that there is a presence of blood within the feces, and determines a source of the blood from within the subject's gastrointestinal tract. The computer processor ( 44 ) generates an output on the output device ( 32 ), at least partially in response thereto. Other applications are also described.

Claims (44)

1. Apparatus for use with feces of a subject that are disposed within a toilet bowl, and an output device, the apparatus comprising:

one or more light sensors that are configured to receive light from the toilet bowl, while the feces are disposed within the toilet bowl; and

a computer processor configured to:

determine that there is a presence of blood within the feces, by analyzing the received light;

determine a source of the blood from within the subject's gastrointestinal tract, by:

measuring an intensity of a first spectral component, within the received light, the first spectral component being centered around a wavelength selected from the group consisting of: a wavelength of between 590 nm and 1000 nm, and a wavelength of between 480 nm and 520 nm;

measuring an intensity of a second spectral component, within the received light, that is centered around a wavelength of between 520 and 590 nm; and

normalizing the measured intensity of the first spectral component with respect to the measured intensity of the second spectral component; and

generate an output on the output device, at least partially in response thereto.

2. The apparatus according to claim 1 , wherein the computer processor is further configured to determine the source of the blood from within the subject's gastrointestinal tract, by measuring an extent to which the blood is spread throughout the feces.

3. The apparatus according to claim 1 , wherein the computer processor is further configured to determine the source of the blood from within the subject's gastrointestinal tract, by measuring a location of the blood within the feces.

4. The apparatus according to claim 1 , wherein the computer processor is configured to generate an output by generating an output indicating that the subject should visit a healthcare professional.

5. The apparatus according to claim 1 , wherein the computer processor is configured to generate an output by generating an output indicating a predicted upcoming inflammatory bowel disease episode.

6. The apparatus according to claim 1 , wherein the computer processor is configured to measure the intensity of the first spectral component by measuring an intensity of a first spectral component, within the received light, that is centered around a wavelength of between 590 nm and 1000 nm.

7. The apparatus according to claim 1 , wherein the computer processor is configured to measure the intensity of the first spectral component by measuring an intensity of a first spectral component, within the received light, that is centered around a wavelength of between 480 nm and 520 nm.

8. The apparatus according to claim 1 , wherein the computer processor is configured to normalize the measured intensity of the first spectral component with respect to the measured intensity of the second spectral component by calculating a ratio between the measured intensity of the first spectral component and the measured intensity of the second spectral component.

9. The apparatus according to claim 8 , wherein the computer processor is configured to measure the intensity of the first spectral component by measuring an intensity of a first spectral component, within the received light, that is centered around a wavelength of between 480 nm and 520 nm.

10. The apparatus according to claim 8 , wherein the computer processor is configured to measure the intensity of the first spectral component by measuring an intensity of a first spectral component, within the received light, that is centered around a wavelength of between 590 nm and 1000 nm.

11. Apparatus for use with feces of a subject that are disposed within a toilet bowl, and an output device, the apparatus comprising:

one or more light sensors that are configured to receive light from the toilet bowl, while the feces are disposed within the toilet bowl; and

a computer processor configured to:

determine that there is a presence of blood within the feces, by analyzing the received light;

determine a source of the blood from within the subject's gastrointestinal tract, by measuring an extent to which the blood is spread throughout the feces; and

generate an output on the output device, at least partially in response thereto.

12. The apparatus according to claim 11 , wherein the computer processor is further configured to determine the source of the blood from within the subject's gastrointestinal tract, by:

measuring an intensity of a first spectral component, within the received light, the first spectral component being centered around a wavelength selected from the group consisting of: a wavelength of between 590 nm and 1000 nm, and a wavelength of between 480 nm and 520 nm;

measuring an intensity of a second spectral component, within the received light, that is centered around a wavelength of between 520 and 590 nm; and

normalizing the measured intensity of the first spectral component with respect to the measured intensity of the second spectral component.

13. The apparatus according to claim 11 , wherein the computer processor is further configured to determine the source of the blood from within the subject's gastrointestinal tract by measuring a location of the blood within the feces.

14. The apparatus according to claim 11 , wherein the computer processor is configured to generate an output by generating an output indicating that the subject should visit a healthcare professional.

15. The apparatus according to claim 11 , wherein the computer processor is configured to generate an output by generating an output indicating a predicted upcoming inflammatory bowel disease episode.

16. A method for use with feces of a subject that are disposed within a toilet bowl, the method comprising:

receiving light from the toilet bowl using one or more light sensors, while the feces are disposed within the toilet bowl; and

using a computer processor:

determining that there is a presence of blood within the feces, by analyzing the received light;

determining a source of the blood from within the subject's gastrointestinal tract, by measuring an extent to which the blood is spread throughout the feces; and

generating an output on an output device, at least partially in response thereto.

17. The method according to claim 16 , wherein determining the source of the blood from within the subject's gastrointestinal tract further comprises:

measuring an intensity of a first spectral component, within the received light, the first spectral component being centered around a wavelength selected from the group consisting of: a wavelength of between 590 nm and 1000 nm, and a wavelength of between 480 nm and 520 nm;

measuring an intensity of a second spectral component, within the received light, that is centered around a wavelength of between 520 and 590 nm; and

normalizing the measured intensity of the first spectral component with respect to the measured intensity of the second spectral component.

18. The method according to claim 16 , wherein determining the source of the blood from within the subject's gastrointestinal tract further comprises measuring a location of the blood within the feces.

19. The method according to claim 16 , wherein generating the output comprises generating an output indicating that the subject should visit a healthcare professional.

20. The method according to claim 16 , wherein generating the output comprises generating an output indicating a predicted upcoming inflammatory bowel disease episode.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2019
From: ATTAR, ISHAY; KAPP-BARNEA, YAARA
To: OUTSENSE DIAGNOSTICS LTD.
Reel/Frame 048612/0795 →
Continuity (2)
Provisional Application 62381288 · Aug 30, 2016
Related Publication 20190195802A1 · Jun 27, 2019
Cited By (4)
US 12,390,200 US 12,392,313 US 12,577,771 US 12,667,260